IRGC
gene geneOn this page
Also known as Iigp5CINEMA
Summary
IRGC (immunity related GTPase cinema, HGNC:28835) is a protein-coding gene on chromosome 19q13.31, encoding Interferon-inducible GTPase 5 (Q6NXR0). Required for sperm motility and therefore male fertility, via positive regulation of spermatozoa fibrous sheath formation.
Predicted to enable GTP binding activity and GTPase activity. Predicted to be involved in positive regulation of flagellated sperm motility. Located in lipid droplet and sperm mitochondrial sheath.
Source: NCBI Gene 56269 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 75 total
- MANE Select transcript:
NM_019612
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28835 |
| Approved symbol | IRGC |
| Name | immunity related GTPase cinema |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Iigp5, CINEMA |
| Ensembl gene | ENSG00000124449 |
| Ensembl biotype | protein_coding |
| OMIM | 620634 |
| Entrez | 56269 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000244314, ENST00000596627
RefSeq mRNA: 1 — MANE Select: NM_019612
NM_019612
CCDS: CCDS12629
Canonical transcript exons
ENST00000244314 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000847442 | 43718493 | 43720021 |
| ENSE00001410155 | 43716076 | 43716142 |
Expression profiles
Bgee: expression breadth broad, 34 present calls, max score 96.76.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0874 / max 75.3312, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176216 | 0.0336 | 3 |
| 176215 | 0.0281 | 3 |
| 176217 | 0.0257 | 3 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.76 | gold quality |
| right testis | UBERON:0004534 | 96.66 | gold quality |
| testis | UBERON:0000473 | 92.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.42 | gold quality |
| adult organism | UBERON:0007023 | 66.65 | gold quality |
| pancreatic ductal cell | CL:0002079 | 56.14 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 55.76 | gold quality |
| myocardium | UBERON:0002349 | 53.55 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.36 | gold quality |
| tibialis anterior | UBERON:0001385 | 51.36 | silver quality |
| colonic mucosa | UBERON:0000317 | 51.18 | gold quality |
| biceps brachii | UBERON:0001507 | 50.85 | gold quality |
| vastus lateralis | UBERON:0001379 | 50.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 50.53 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| thymus | UBERON:0002370 | 48.90 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.42 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 1298.83 |
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The immunity-related GTPase IRGC mediates interaction between lipid droplets and mitochondria to facilitate sperm motility. (PMID:37195149)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | irgf3 | ENSDARG00000062820 |
| danio_rerio | si:ch73-171o20.1 | ENSDARG00000062828 |
| danio_rerio | irgf1 | ENSDARG00000070774 |
| danio_rerio | irgf2 | ENSDARG00000092249 |
| mus_musculus | Irgc | ENSMUSG00000062028 |
| rattus_norvegicus | Irgc | ENSRNOG00000024257 |
Paralogs (1): IRGM (ENSG00000237693)
Protein
Protein identifiers
Interferon-inducible GTPase 5 — Q6NXR0 (reviewed: Q6NXR0)
Alternative names: Immunity-related GTPase cinema 1
All UniProt accessions (3): J7NNX4, M0R0T1, Q6NXR0
UniProt curated annotations — full annotation on UniProt →
Function. Required for sperm motility and therefore male fertility, via positive regulation of spermatozoa fibrous sheath formation.
Subcellular location. Cell projection. Cilium. Flagellum. Lipid droplet.
Tissue specificity. Abundantly expressed in semen (at protein level).
Miscellaneous. Asthenozoospermic patients show a decrease in IRGC protein abundance in semen samples and a loss of colocalization with the mitochondria which suggests a role for IRGC in sperm motility.
Similarity. Belongs to the TRAFAC class dynamin-like GTPase superfamily. IRG family.
RefSeq proteins (1): NP_062558* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007743 | Immunity-related_GTPase-like | Family |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR030385 | G_IRG_dom | Domain |
| IPR051515 | IRG | Family |
Pfam: PF05049
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (10 total): binding site 4, modified residue 2, chain 1, domain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6NXR0-F1 | 68.67 | 0.14 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 62–69; 87–91; 169–171; 216–218
Post-translational modifications (2): 247, 304
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_CILIUM_MOVEMENT, GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS, MORF_EPHA7, MORF_RAB3A, GOBP_REGULATION_OF_CILIUM_MOVEMENT, MORF_WNT1, MORF_DCC, GOCC_MOTILE_CILIUM, GOCC_SPERM_MIDPIECE, GOCC_CILIUM, GOMF_GTPASE_ACTIVITY
GO Biological Process (1): positive regulation of flagellated sperm motility (GO:1902093)
GO Molecular Function (5): GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166), protein binding (GO:0005515), hydrolase activity (GO:0016787)
GO Cellular Component (7): lipid droplet (GO:0005811), membrane (GO:0016020), sperm flagellum (GO:0036126), sperm mitochondrial sheath (GO:0097226), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| positive regulation of cilium movement | 1 |
| flagellated sperm motility | 1 |
| regulation of flagellated sperm motility | 1 |
| positive regulation of cilium-dependent cell motility | 1 |
| positive regulation of reproductive process | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular membraneless organelle | 1 |
| 9+2 motile cilium | 1 |
| sperm midpiece | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
881 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IRGC | DCTN4 | Q9UJW0 | 493 |
| IRGC | ATG16L1 | Q676U5 | 453 |
| IRGC | UVRAG | Q9P2Y5 | 397 |
| IRGC | ATG5 | Q9H1Y0 | 396 |
| IRGC | MTMR14 | Q8NCE2 | 379 |
| IRGC | WIPI1 | Q5MNZ9 | 372 |
| IRGC | ATG101 | Q9BSB4 | 371 |
| IRGC | ZIC2 | O95409 | 369 |
| IRGC | NBR1 | Q14596 | 368 |
| IRGC | GOPC | Q9HD26 | 363 |
| IRGC | TSPAN8 | P19075 | 353 |
| IRGC | VDAC1 | P21796 | 353 |
| IRGC | DAPK1 | P53355 | 353 |
| IRGC | WIPI2 | Q9Y4P8 | 353 |
| IRGC | A0A0J9YVX5 | A0A0J9YVX5 | 351 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HNRNPK | IRGC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNDBP1 | IRGC | psi-mi:“MI:0915”(physical association) | 0.560 |
| IRGC | RAP1GDS1 | psi-mi:“MI:0914”(association) | 0.530 |
| MYF6 | TBC1D4 | psi-mi:“MI:0914”(association) | 0.350 |
| IRGC | RPS6KA3 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| IRGC | HNRNPK | psi-mi:“MI:0915”(physical association) | 0.000 |
| IRGC | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (30): METTL7B (Affinity Capture-MS), RPS6KA1 (Affinity Capture-MS), FBXL18 (Affinity Capture-MS), PI4K2A (Affinity Capture-MS), IRGC (Affinity Capture-MS), RHOA (Affinity Capture-MS), SLC26A6 (Affinity Capture-MS), AP3S1 (Affinity Capture-MS), RAP1GDS1 (Affinity Capture-MS), MCU (Affinity Capture-MS), ATP12A (Affinity Capture-MS), OMA1 (Affinity Capture-MS), RPS6KA3 (Affinity Capture-MS), RPS6KA2 (Affinity Capture-MS), HNRNPK (Two-hybrid)
ESM2 similar proteins: A0A140LIF8, A0JN92, A1Z198, A6H603, B1ARD6, B1ARD8, D9I2F9, D9I2G1, D9I2G3, D9I2G4, D9I2H0, E1BPN0, G1SRW8, O02799, P0C7P3, P52630, Q08AF3, Q0GKD5, Q0P3U3, Q149M9, Q1LXZ7, Q1LZ50, Q2LKU9, Q2LKV5, Q2LKW6, Q32KW9, Q5I0J8, Q5NCI0, Q5RCZ8, Q5RFJ8, Q5SY16, Q5U311, Q60766, Q63035, Q68D06, Q6AYC2, Q6AYF9, Q6IEE8, Q6NXR0, Q7Z7L1
Diamond homologs: A0A140LIF8, A1A4Y4, Q0GUM3, Q32KW9, Q3T9E4, Q60766, Q62293, Q6AYC2, Q6AYF9, Q6NXR0, Q9DCE9, Q9QZ85, Q8C262, Q8VIM9, Q8WZA9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 4 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
189 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:43716086:G:T | donor_gain | 0.9900 |
| 19:43718488:TGCA:T | acceptor_loss | 0.9700 |
| 19:43718489:GCAG:G | acceptor_loss | 0.9700 |
| 19:43718490:CAGGC:C | acceptor_loss | 0.9700 |
| 19:43718491:A:AT | acceptor_loss | 0.9700 |
| 19:43716086:G:GT | donor_gain | 0.9600 |
| 19:43718491:A:AG | acceptor_gain | 0.9500 |
| 19:43718492:G:GG | acceptor_gain | 0.9500 |
| 19:43718492:GGC:G | acceptor_gain | 0.9300 |
| 19:43718488:T:TA | acceptor_gain | 0.9100 |
| 19:43716077:GC:G | donor_gain | 0.9000 |
| 19:43716108:A:T | donor_gain | 0.9000 |
| 19:43716140:CAG:C | donor_loss | 0.9000 |
| 19:43716141:AGGTG:A | donor_loss | 0.9000 |
| 19:43716142:GG:G | donor_loss | 0.9000 |
| 19:43716143:GTGA:G | donor_loss | 0.9000 |
| 19:43716144:T:G | donor_loss | 0.9000 |
| 19:43716145:GAG:G | donor_loss | 0.9000 |
| 19:43716078:C:G | donor_gain | 0.8700 |
| 19:43716867:TGAG:T | acceptor_gain | 0.8700 |
| 19:43718491:AGGC:A | acceptor_gain | 0.8700 |
| 19:43718492:GGCG:G | acceptor_gain | 0.8700 |
| 19:43716146:AGTCC:A | donor_loss | 0.8400 |
| 19:43718491:AG:A | acceptor_gain | 0.8100 |
| 19:43718492:GG:G | acceptor_gain | 0.8100 |
| 19:43718492:GGCGC:G | acceptor_gain | 0.8000 |
| 19:43716868:G:GC | acceptor_gain | 0.7900 |
| 19:43716147:G:C | donor_loss | 0.7700 |
| 19:43716139:GCAG:G | donor_gain | 0.7500 |
| 19:43718669:CCAGG:C | acceptor_gain | 0.7500 |
AlphaMissense
2959 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:43719195:T:C | F213L | 0.990 |
| 19:43719197:C:A | F213L | 0.990 |
| 19:43719197:C:G | F213L | 0.990 |
| 19:43719741:G:C | D395H | 0.989 |
| 19:43719744:G:C | A396P | 0.978 |
| 19:43718759:G:C | K67N | 0.977 |
| 19:43718759:G:T | K67N | 0.977 |
| 19:43719111:T:C | F185L | 0.977 |
| 19:43719113:C:A | F185L | 0.977 |
| 19:43719113:C:G | F185L | 0.977 |
| 19:43719735:G:C | A393P | 0.975 |
| 19:43719743:C:A | D395E | 0.975 |
| 19:43719743:C:G | D395E | 0.975 |
| 19:43718774:T:A | N72K | 0.974 |
| 19:43718774:T:G | N72K | 0.974 |
| 19:43719471:T:C | F305L | 0.973 |
| 19:43719473:T:A | F305L | 0.973 |
| 19:43719473:T:G | F305L | 0.973 |
| 19:43719196:T:C | F213S | 0.972 |
| 19:43718758:A:T | K67M | 0.971 |
| 19:43718758:A:C | K67T | 0.970 |
| 19:43719231:T:C | F225L | 0.967 |
| 19:43719233:T:A | F225L | 0.967 |
| 19:43719233:T:G | F225L | 0.967 |
| 19:43719751:G:C | R398P | 0.966 |
| 19:43719061:C:T | T168I | 0.962 |
| 19:43719065:G:C | K169N | 0.962 |
| 19:43719065:G:T | K169N | 0.962 |
| 19:43719205:C:T | S216F | 0.962 |
| 19:43719690:T:C | F378L | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1000120461 (19:43716757 G>A), RS1000267095 (19:43718272 G>A,T), RS1000514890 (19:43717048 G>A), RS1001115186 (19:43715759 G>A), RS1001768317 (19:43718837 G>A), RS1001778092 (19:43718316 C>A), RS1001802311 (19:43717996 G>A), RS1002220756 (19:43718604 A>T), RS1003056497 (19:43715150 C>T), RS1003443833 (19:43719375 G>A), RS1004003189 (19:43714243 G>A), RS1004687561 (19:43715001 G>A), RS1005136620 (19:43717769 A>T), RS1005822519 (19:43717582 G>A), RS1006410843 (19:43716487 G>A)
Disease associations
OMIM: gene MIM:620634 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| licochalcone B | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Rotenone | increases expression | 1 |
| Testosterone | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.